美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kailera Therapeutics, Inc.

17.75

+1.217.32%

盤後：17.750.00000.00%16:10 EDT

成交量：132.39萬

成交額：2,336.09萬

市值：22.99億

市盈率：-7.87

高：18.19

開：16.75

低：16.54

收：16.54

52周最高：28.23

52周最低：16.37

股本：1.30億

流通股本：4,492.19萬

量比：1.35

換手率：2.95%

股息：- -

股息率：- -

每股收益(TTM):-2.2543

每股收益(LYR):-7,819.9811

淨資產收益率：-36.90%

總資產收益率：-22.73%

市淨率：2.06

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Kailera Therapeutics, Inc.

交易所：

NASDAQ

成立時間：

2024

員工人數：

- -

公司地址：

180 Third Avenue,4th Floor,Waltham,Massachusetts,United States

官網：

http://www.kailera.com

郵編：

02451

電話：

傳真：

- -

簡介：

Kailera Therapeutics, Inc.於2024年5月8日根據特拉華州法律註冊成立。該公司是一家處於臨床階段的生物技術公司，致力於通過推進多元化的研發管線，引領肥胖症治療的新時代。目前，該公司正在快速推進四款處於臨床階段的候選產品，這些產品利用多種基於胰高血糖素樣肽-1 (GLP-1) 的作用機制和給藥途徑。

董事

名稱

職位

John F. Milligan

Chairman and Director

Ronald C. Renaud, Jr.

Chief Executive Officer,Director and President

Adam Koppel

Independent Director

Andrew Kaplan

Independent Director

Christopher Hite

Independent Director

Frank Clyburn, Jr.

Independent Director

Martin Mackay

Independent Director

Michael Gladstone

Independent Director

Yuting Liu

Independent Director

股東

名稱

職位

Ronald C. Renaud, Jr.

Chief Executive Officer,Director and President

Paul Burgess

Chief Business Officer and Chief Operating Officer

Douglas Pagán

Chief Financial Officer

Jamie Coleman

Chief Commercial Officer

Paula Cloghessy

Chief People Officer

Scott Akamine

Chief Legal Officer and Secretary

Scott Wasserman

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/KLRA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KLRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics, Inc.","latestPrice":17.75,"timestamp":1787688000000,"preClose":16.54,"halted":0,"volume":1323871,"hourTrading":{"tag":"盘后","latestPrice":17.75,"preClose":17.75,"latestTime":"16:10 EDT","volume":3983,"amount":70698.25,"timestamp":1787688604877,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07315598548972194,"floatShares":44921899,"shares":129537300,"eps":-2.254252,"marketStatus":"盤後交易","change":1.21,"latestTime":"08-25 16:10:19 EDT","open":16.75,"high":18.19,"low":16.54,"amount":23360895.2789,"amplitude":0.099758,"askPrice":17.75,"askSize":101,"bidPrice":16.5,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-2.254252,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":16.54,"preHourTrading":{"tag":"盘前","latestPrice":16.82,"preClose":16.54,"latestTime":"09:12 EDT","volume":142,"amount":2396.5300239999997,"timestamp":1787663555308,"change":0.28,"changeRate":0.016929,"amplitude":0.000605},"postHourTrading":{"tag":"盘后","latestPrice":17.75,"preClose":17.75,"latestTime":"16:10 EDT","volume":3983,"amount":70698.25,"timestamp":1787688604877,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.349094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","floatShares":44921899,"roa":"-22.73%","roe":"-36.90%","lyrEps":-7819.9811,"volumeRatio":1.349094,"shares":129537300,"dividePrice":0,"high":18.19,"amplitude":0.099758,"preClose":16.54,"low":16.54,"week52Low":16.37,"pbRate":"2.06","week52High":28.2271,"institutionHeld":0,"latestPrice":17.75,"committee":-0.669421,"eps":-2.254252,"divideRate":0,"volume":1323871,"delay":0,"ttmEps":-2.254252,"open":16.75,"prevYearClose":16,"prevWeekClose":17.17,"prevMonthClose":16.94,"prevQuarterClose":22.03,"fiveDayClose":17.83,"twentyDayClose":16.74,"sixtyDayClose":22.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"KLRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-1.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1783656000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRA","date":"2026-08-24","current":-7.936114,"percent":1,"low":-21.871461,"twenty":-19.582567,"median":-16.636224,"eighty":-11.274789,"high":-7.618086,"avg":-15.350689,"sd":4.227414,"marketCap":2225981916},"quantilePoints":[{"date":"2026-04-17","current":-12.669466,"twenty":-12.511098,"median":-12.273546,"eighty":-12.035993,"marketCap":1887180368},{"date":"2026-04-24","current":-20.824025,"twenty":-20.917019,"median":-20.433783,"eighty":-14.17085,"marketCap":3101842710},{"date":"2026-05-01","current":-21.741015,"twenty":-21.413894,"median":-20.305085,"eighty":-18.829635,"marketCap":3238432850},{"date":"2026-05-08","current":-19.540824,"twenty":-21.576784,"median":-20.824025,"eighty":-19.524523,"marketCap":2910703445},{"date":"2026-05-15","current":-18.697273,"twenty":-21.521865,"median":-20.058623,"eighty":-18.676401,"marketCap":2785052251},{"date":"2026-05-22","current":-18.332024,"twenty":-21.403595,"median":-19.540824,"eighty":-18.304195,"marketCap":2730646579},{"date":"2026-05-29","current":-19.949555,"twenty":-21.097481,"median":-19.520448,"eighty":-18.332024,"marketCap":2971585983},{"date":"2026-06-05","current":-18.253756,"twenty":-20.940268,"median":-19.530636,"eighty":-18.332024,"marketCap":2718988220},{"date":"2026-06-12","current":-16.992777,"twenty":-20.824025,"median":-19.392985,"eighty":-17.13192,"marketCap":2531159115},{"date":"2026-06-18","current":-16.636224,"twenty":-20.511831,"median":-18.758148,"eighty":-17.050173,"marketCap":2478048816},{"date":"2026-06-26","current":-12.75669,"twenty":-20.227867,"median":-18.684228,"eighty":-17.050173,"marketCap":2676825461},{"date":"2026-07-02","current":-12.855483,"twenty":-20.165517,"median":-18.622605,"eighty":-16.764931,"marketCap":2697555958},{"date":"2026-07-10","current":-12.9728,"twenty":-20.033041,"median":-18.410291,"eighty":-15.433812,"marketCap":2722173424},{"date":"2026-07-17","current":-11.311837,"twenty":-19.949555,"median":-18.314631,"eighty":-13.521103,"marketCap":2373641938},{"date":"2026-07-24","current":-10.743775,"twenty":-19.944337,"median":-17.453687,"eighty":-12.859187,"marketCap":2254441579},{"date":"2026-07-31","current":-10.527665,"twenty":-19.923466,"median":-17.13192,"eighty":-12.704356,"marketCap":2209093616},{"date":"2026-08-07","current":-11.651439,"twenty":-19.849563,"median":-17.071044,"eighty":-11.79378,"marketCap":2444903022},{"date":"2026-08-14","current":-7.973035,"twenty":-19.724778,"median":-16.992777,"eighty":-11.573639,"marketCap":2329696857},{"date":"2026-08-21","current":-7.746755,"twenty":-19.603438,"median":-16.640572,"eighty":-11.334065,"marketCap":2263578582},{"date":"2026-08-24","current":-7.618086,"twenty":-19.582567,"median":-16.636224,"eighty":-11.274789,"marketCap":2225981916}],"updateTime":1787685677563},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1899116257,"yearFounded":2024,"address":"180 Third Avenue,4th Floor,Waltham,Massachusetts,United States","zipCode":"02451","officePhone":"781 317 0290","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.kailera.com","stockEarnings":[{"period":"1week","weight":-0.1064},{"period":"1month","weight":-0.065},{"period":"3month","weight":-0.2332},{"period":"6month","weight":0.0337},{"period":"ytd","weight":0.0337}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.1831},{"period":"ytd","weight":0.1196}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Kailera Therapeutics, Inc.於2024年5月8日根據特拉華州法律註冊成立。該公司是一家處於臨床階段的生物技術公司，致力於通過推進多元化的研發管線，引領肥胖症治療的新時代。目前，該公司正在快速推進四款處於臨床階段的候選產品，這些產品利用多種基於胰高血糖素樣肽-1 (GLP-1) 的作用機制和給藥途徑。","exchange":"NASDAQ","name":"Kailera Therapeutics, Inc.","nameEN":"Kailera Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":{"directors":[{"name":"John F. Milligan","position":"Chairman and Director"},{"name":"Ronald C. Renaud, Jr.","position":"Chief Executive Officer,Director and President"},{"name":"Adam Koppel","position":"Independent Director"},{"name":"Andrew Kaplan","position":"Independent Director"},{"name":"Christopher Hite","position":"Independent Director"},{"name":"Frank Clyburn, Jr.","position":"Independent Director"},{"name":"Martin Mackay","position":"Independent Director"},{"name":"Michael Gladstone","position":"Independent Director"},{"name":"Yuting Liu","position":"Independent Director"}],"executives":[{"name":"Ronald C. Renaud, Jr.","position":"Chief Executive Officer,Director and President"},{"name":"Paul Burgess","position":"Chief Business Officer and Chief Operating Officer"},{"name":"Douglas Pagán","position":"Chief Financial Officer"},{"name":"Jamie Coleman","position":"Chief Commercial Officer"},{"name":"Paula Cloghessy","position":"Chief People Officer"},{"name":"Scott Akamine","position":"Chief Legal Officer and Secretary"},{"name":"Scott Wasserman","position":"Chief Medical Officer"}]}}}